MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025)
MeiraGTx Holdings (MGTX) reported Current Deferred Revenue of $1.8 million for Q4 2025, down 63.21% on a YoY basis from $4.8 million in Q4 2024, and down 35.23% quarter-over-quarter from $2.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Current Deferred Revenue for 7 years, with the latest figure at $1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue fell 63.21% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (down 63.21% YoY), and the FY2025 full-year result was $1.8 million, down 63.21% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $1.8 million, down from $2.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $25.6 million in Q1 2021, with the low at $1.8 million in Q4 2025.
- Historically, Current Deferred Revenue has averaged $11.8 million across 5 years, with a median of $10.0 million in 2023.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue sank 80.65% — and 2024, when it jumped 64.97%.
- MeiraGTx Holdings' Current Deferred Revenue stood at $21.8 million in 2021, then slumped by 30.69% to $15.1 million in 2022, then slumped by 80.65% to $2.9 million in 2023, then jumped by 64.97% to $4.8 million in 2024, then slumped by 63.21% to $1.8 million in 2025.
- The last three Current Deferred Revenue figures came in at $1.8 million (Q4 2025), $2.7 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 13.69 Mn |
| Dec 31, 2022 | 15.12 Mn |
| Sep 30, 2022 | 18.88 Mn |
| Jun 30, 2022 | 21.21 Mn |
| Mar 31, 2022 | 20.19 Mn |
| Dec 31, 2021 | 21.82 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 24.88 Mn |
| Mar 31, 2021 | 25.60 Mn |